Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancer

E-ISSN： 1097-0142|119|20|3604-3609

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.20, 2013-10, pp. : 3604-3609

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of Endoglin in Primary Endometrial Cancer

Oncology, Vol. 81, Iss. 3-4, 2011-11 ,pp. : 243-250

Karger

Access to resources Recommend Favorite

Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas

INTERNATIONAL JOURNAL OF CANCER, Vol. 126, Iss. 8, 2010-04 ,pp. : 1944-1954

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer

By Ling Zhi-Qiang Li Pei Ge Ming-Hua Zhao Xuan Hu Fu-Jun Fang Xian-Hua Dong Zi-Min Mao Wei-Min

International Journal of Molecular Medicine, Vol. 27, Iss. 5, 2011-05 ,pp. : 625-635

Spandidos Publications

Access to resources Recommend Favorite

Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer

CANCER, Vol. 121, Iss. 9, 2015-05 ,pp. : 1395-1404

John Wiley & Sons Inc

Access to resources Recommend Favorite

Promoter Hypermethylation in Tumour Suppressor Genes Shows Association with Stage, Grade and Invasiveness of Bladder Cancer

Oncology, Vol. 75, Iss. 3-4, 2008-09 ,pp. : 145-151

Karger

Access to resources Recommend Favorite